Previous close | 66.63 |
Open | 66.85 |
Bid | 65.62 x 900 |
Ask | 65.99 x 3100 |
Day's range | 65.64 - 66.84 |
52-week range | 52.65 - 72.12 |
Volume | |
Avg. volume | 5,057,901 |
Market cap | 204.543B |
Beta (5Y monthly) | 0.23 |
PE ratio (TTM) | 103.11 |
EPS (TTM) | 0.64 |
Earnings date | N/A |
Forward dividend & yield | 1.45 (2.18%) |
Ex-dividend date | 11 Aug 2022 |
1y target est | 76.71 |
Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
Astrazeneca (AZN) closed at $66.28 in the latest trading session, marking a -1.97% move from the prior day.
AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene are part of the Zacks top Analyst Blog.